The Future Is Digital: Telemedicine Is Helping Open Doors to More Comprehensive Care in MS
November 25th 2020As the adoption of telemedicine rises, the ability to incorporate digital and telehealth-based therapies offers clinicians a unique opportunity to supplement the comprehensive care model.
NeuroVoices: Michael Okun, MD, on Reforming the Device Approval Process
November 25th 2020Michael Okun, MD, executive director of the Norman Fixel Institute for Neurological Diseases sat down to discuss his viewpoint paper on changing the approval system for neurotechnological devices in rare diseases.
Award Will Fund Study of Underlying Biology of Neurometabolic Disorder
November 24th 2020A University of Miami Miller School of Medicine neuroscientist and molecular biologist is leading a collaborative study that could develop new insights into how cellular processes affect neurodegenerative diseases.